Gensight Biologics

Developer of viral vector-based gene therapies for retinal neurodegenerative diseases

placeParis, Ile De France, France calendar_todayFounded 2011 groups23 employees language gensight-biologics.com

Innovation

10 patent families (7 granted) — focus: Human necessities, Physics & computing; filing pace steady.

Social engagement

Social engagement: 9.8K social following, 10 posts in the last 12 months — below the industry typical range.

Recent activity

20 May 2026
Recognition
25 Mar 2026
Event
4th International Ophthalmology Conference
20 Mar 2026
Event
52nd annual meeting of the North American Neuro-Ophthalmology Society (NANOS)
Coming soon